Ionic Capital Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.2M Buy
27,796
+7,200
+35% +$612K 0.32% 20
2026
Q1
$1.77M Sell
20,596
-11,000
-35% -$987K 0.13% 32
2025
Q4
$2.76M Sell
31,596
-15,000
-32% -$1.14M 0.35% 19
2025
Q3
$2.67M Buy
46,596
+4,800
+11% +$276K 0.28% 18
2025
Q2
$2.47M Buy
41,796
+16,500
+65% +$1.07M 0.71% 19
2025
Q1
$1.85M Hold
25,296
0.24% 19
2024
Q4
$2.09M Hold
25,296
0.21% 27
2024
Q3
$1.81M Sell
25,296
-11,074
-30% -$782K 0.31% 51
2024
Q2
$2.49M Sell
36,370
-14,630
-29% -$874K 0.43% 37
2024
Q1
$2.74M Buy
+51,000
New +$2.74M 0.88% 29

Other funds holding GMED

Ionic Capital Management's GMED Position: Q2 2026 in Review

Ionic Capital Management increased its Globus Medical (GMED) stake by 35% in Q2 2026, buying an estimated $612K and bringing the position to 27,796 shares worth $2.2M. The position accounts for 0.32% of the portfolio, ranked #20.

Ionic Capital Management first reported a position in GMED in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.76M in Q4 2025. 597 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Ionic Capital Management held 27,796 shares of Globus Medical worth $2.2M as of Q2 2026.
  • Ionic Capital Management bought 7,200 Globus Medical shares in Q2 2026, an estimated $612K.
  • Globus Medical made up 0.32% of Ionic Capital Management's portfolio in Q2 2026, its #20 holding.
  • Ionic Capital Management first reported a position in Globus Medical in Q1 2024 and has held it in 10 quarters since.
  • Ionic Capital Management's Globus Medical position peaked at $2.76M in Q4 2025.
  • 597 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Ionic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.